Morgan Stanley’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $222K | Sell |
|
|||||
|
2022
Q4 | $1.84M | Sell |
|
|||||
|
2022
Q3 | $3.93M | Buy |
|
|||||
|
2022
Q2 | $4.94M | Buy |
|
|||||
|
2022
Q1 | $10.4M | Buy |
|
|||||
|
2021
Q4 | $295K | Buy |
|
|||||
|
2021
Q3 | $175K | Sell |
|
|||||
|
2021
Q2 | $617K | Buy |
|
|||||
|
2021
Q1 | $174K | Sell |
|
|||||
|
2020
Q4 | $243K | Buy |
|
|||||
|
2020
Q3 | $278K | Buy |
|
|||||
|
2020
Q2 | $168K | Sell |
|
|||||
|
2020
Q1 | $210K | Sell |
|
|||||
|
2019
Q4 | $414K | Buy |
|
|||||
|
2019
Q3 | $152K | Buy |
|
|||||
|
2019
Q2 | $72K | Sell |
|
|||||
|
2019
Q1 | $101K | Sell |
|
|||||
|
2018
Q4 | $403K | Buy |
|
|||||
|
2018
Q3 | $317K | Sell |
|
|||||
|
2018
Q2 | $915K | Buy |
|
|||||
|
2018
Q1 | $849K | Sell |
|
|||||
|
2017
Q4 | $607K | Sell |
|
|||||
|
2017
Q3 | $1.49M | Buy |
|
|||||
|
2017
Q2 | $174K | Sell |
|
|||||
|
2017
Q1 | $278K | Buy |
|